FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.
Position in DXCM — Dexcom Inc
CIK 1280487
TURIN, L6
Position in DXCM
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$14,596,024
+$12,788,578 QoQ
Shares Held
216,719
+653.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#170
of 966 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. holds $57,350,325 across 12 Medical Devices names. DXCM ranks #2 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BRKR |
Bruker Corp
|
284,435 | $17,117,298 | |
| 2 | DXCM |
Dexcom Inc
This page
|
216,719 | $14,596,024 | |
| 3 | EW |
Edwards Lifesciences Corp
|
138,960 | $12,570,321 | |
| 4 | BSX |
Boston Scientific Corp
|
83,972 | $3,583,924 | |
| 5 | ABT |
Abbott Laboratories
|
27,794 | $2,522,027 | |
| 6 | BIO |
Bio-Rad Laboratories, Inc.
|
8,221 | $2,413,767 | |
| 7 | GKOS |
GLAUKOS Corp
|
10,660 | $1,489,841 | |
| 8 | TNDM |
Tandem Diabetes Care Inc
|
84,862 | $1,280,567 |
All Filings in DXCM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,596,024 | 216,719 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $1,807,446 | 28,781 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $1,858,426 | 28,001 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||